REVIEW Trityl olmesartan medoxomil is a key intermediate used in the preparation of olmesartan medoxomil, an angiotension II receptor antagonist, used in the treatment of hypertension.
REFERENCES
[1]
Yanagisawa, Hiroaki; Shimoji, Yasuo; Fujimoto, Koichi; Kanazaki, Takuro; Anemiya, Yoshiya; Koike, Hiroyuki; Sada, Toshio, Prepeparation of 1-[(carboxy-biphenylyl)methyl]imidazole-5-carboxylates and analogs as angiotensin II antagonists. Eur. Pat. Appl. (1992), EP 503785 A1 19920916.
[2]
Zhang, Fuli; Wu, Taizhi Preparation of olmesartan medoxomil. PCT Int. Appl. (2004), WO 2004085428 A1 20041007.
[3]
Hedvati, Lilach; Pilarsky, Gideon; Process for the preparation of olmesartan medoxomil. PCT Int. Appl. (2006), WO 2006029056 A1 20060316.
[4]
Ramanjaneyulu, Gorantla Seeta; Mohan, Bandari; Ray, Purna Chandra; Sethi, Madhuresh Kumar; Rawat, Vijendra Singh; Krishna, Yerramalla Raja; Lakshminarayana, Vemula; Srinivas, Mamidi; Process for the preparation of olmesartan medoxomil. PCT Int. Appl. (2007), WO 2007148344 A2 20071227.
These chemical products are for research and development use only. They are not for diagnostic, therapeutic, cosmetic, or human and animal uses. They are not sold to individuals. Additional restrictions may apply.
New customers undergo an internal onboarding process. As part of this process, new customers may be asked for more information. CATEGORIES APIs and Bioactives > Angiotensin Receptor Blockers
Add to Favorites 
Delete from Favorites 
